Academic Journals Database
Disseminating quality controlled scientific knowledge

New developments in the management of congenital Factor XIII deficiency

ADD TO MY LIST
 
Author(s): Fadoo Z | Merchant Q | Rehman KA

Journal: Journal of Blood Medicine
ISSN 1179-2736

Volume: 2013;
Issue: default;
Start page: 65;
Date: 2013;
Original page

ABSTRACT
Zehra Fadoo,1 Quratulain Merchant,2,* Karim Abdur Rehman2,* 1Department of Pediatrics and Child Health, 2Medical College, Aga Khan University, Karachi, Pakistan *These authors contributed equally to this workAbstract: Congenital Factor XIII (FXIII) deficiency is a rare, inherited, autosomal recessive coagulation disorder. Most mutations of this condition are found in the A-subunit with almost half these being missense mutations. Globally, approximately one in three million people suffer from this deficiency. Factor XIII deficiency is associated with severe life threatening bleeding, intracranial hemorrhage, impaired wound healing, and recurrent pregnancy losses. FXIII is known to have a potential role in mediating inflammatory processes, insulin resistance, bone metabolism, neoplasia, and angiogenesis. The algorithm provided for FXIII diagnosis and classification will enable prompt identification and early intervention for controlling potential life threatening complications. Prophylactic replacement therapy using blood products containing FXIII such as fresh frozen plasma, cryoprecipitate, or using FXIII concentrate remains the mainstay for the management of FXIII deficiency. In most parts of the world, cryoprecipitate and plasma transfusions are the only treatments available. Management developments have revealed the effectiveness and safety of recombinant FXIII concentrate for prophylaxis and treatment. The aim of this review is to provide an overview of advancements made in the management of FXIII deficiency from the time it was first detected, highlighting novel developments made in recent years. Greater research is warranted in identifying novel approaches to manage FXIII deficiency in light of its underlying pathophysiology.Keywords: Factor XIII, Factor XIII deficiency, treatment, diagnosis, inherited coagulative disorders

Tango Jona
Tangokurs Rapperswil-Jona

     Save time & money - Smart Internet Solutions